HA-155
N/A
Report date: 2022/06/29 14:24:48
NME
Base Information
Drug NameHA-155
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Netherlands Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesThe Netherlands Cancer Institute
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A